Vivaldi Therapeutics
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2929 Arch St, Philadelphia, Pennsylvania...Website
vivaldi.bioRevenue
<$5 MillionIndustry
About Vivaldi Therapeutics
Vivaldi Therapeutics Org Chart
Is Vivaldi Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Vivaldi Therapeutics is spiking on competitors!
Product Launch: Get notified when Vivaldi Therapeutics launches new products
Check if Vivaldi Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Vivaldi Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Vivaldi Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Vivaldi Therapeutics
Earning: See what the market has to say on Vivaldi Therapeutics recently announced quarterly report
Vivaldi Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Vivaldi Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vivaldi Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vivaldi Therapeutics.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivaldi Therapeutics
Vivaldi Therapeutics is a clinical-stage biopharmaceutical company focused on advancing oncology treatments through innovative combinatorial therapies. Founded by experts in interventional oncology and immuno-oncology, the company aims to enhance cancer care by leveraging multi-target immuno-oncology mechanisms. Their approach seeks to locally prim... Read More